Centrifugal Blood Pumps Market Size, Share, Growth Trends, Industry Analysis and Forecast to 2030
Report ID: RC66731 | Report Format: PDF + Excel | Last Updated: September 13th, 2025The global centrifugal blood pumps market size valued at over USD 0.1 billion in 2024 and estimated to expand at a significant CAGR of over 5% during the forecast period from 2025 to 2030. The rapid growth in heart surgeries around the world is a primary factor to drive the market growth. According to the Centers for Disease Control and Prevention (CDC), around 655,000 Americans die every year in the United States due to heart disease and coronary heart disease is one of the most common among them.
The increasing incidence of cardiac disorders and heart transplants is expected to increase the demand for centrifugal blood pumps over the forecast years. Moreover, the increasing demand for cardiac assist devices for the treatment of cardiopulmonary bypass is expected to drive the market growth over the forecast period.
Market Outlook:
| Benchmark Year | 2024 | ||
| Market Size | > USD 0.1 Bn in 2024 | ||
| Market Growth (CAGR) | > 5% (2025-2030) | ||
| Largest Market Share | North America | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Baxter International Inc., Medtronic PLC., Braile Biomedica Ltd., Getinge AB., and 3-M Health Care |
Emerging Trends Shaping the Centrifugal Blood Pumps Market:
The centrifugal blood pumps market is experiencing robust growth due to increasing demand for advanced circulatory support devices in cardiac surgeries and critical care. Key trends include the rising adoption of minimally invasive and durable pump systems that offer enhanced hemodynamic stability and reduced hemolysis. Technological innovations, such as magnetically levitated impellers and smart sensors for real-time monitoring, are becoming standard features, improving patient safety and operational efficiency. Additionally, the growing prevalence of cardiovascular diseases, coupled with an aging population worldwide, is driving the demand for reliable blood pump solutions in hospitals and specialized cardiac care centers.
Another notable trend is the shift toward portable and long-term circulatory support devices, including extracorporeal membrane oxygenation (ECMO) systems and left ventricular assist devices (LVADs), which integrate centrifugal pumps for improved outcomes. Market expansion is also supported by increased investments in research and development, particularly in Asia-Pacific and North America, where advanced healthcare infrastructure and favorable reimbursement policies facilitate adoption. Strategic collaborations between device manufacturers and hospitals are promoting product innovation and rapid commercialization, while regulatory approvals for next-generation devices are shaping the competitive landscape and enhancing overall market growth.
Centrifugal Blood Pumps Market Driving Factors:
- Increasing prevalence of cardiovascular diseases: Cardiovascular diseases, such as heart failure, are on the rise globally. Centrifugal blood pumps are commonly used in cardiac surgery and circulatory support to assist or replace the pumping function of the heart. The growing incidence of cardiovascular diseases is driving the demand for centrifugal blood pumps.
- Technological advancements: Advances in medical device technology have led to the development of more sophisticated and efficient centrifugal blood pumps. These pumps offer improved performance, durability, and safety features, making them more attractive for use in medical settings. Technological advancements have expanded the applications of centrifugal blood pumps and increased their adoption.
- Favorable reimbursement policies: Reimbursement policies and support from healthcare systems play a crucial role in the adoption of centrifugal blood pumps. In many countries, reimbursement for cardiac surgeries and circulatory support devices, including centrifugal blood pumps, is available, making them more accessible to patients and healthcare providers.
- Increasing preference for minimally invasive procedures: Minimally invasive cardiac surgeries are gaining popularity due to their advantages, such as reduced hospital stays, faster recovery, and lower post-operative complications. Centrifugal blood pumps are compatible with minimally invasive procedures and can be used in conjunction with other devices to provide circulatory support during these procedures.
- Growing geriatric population: The aging population is prone to cardiovascular diseases and may require cardiac surgeries or circulatory support. As the global population continues to age, there is a higher demand for cardiac interventions, leading to an increased need for centrifugal blood pumps.
- Advantages over traditional pumps: Centrifugal blood pumps offer several advantages over traditional pumps, such as improved hemocompatibility, reduced risk of hemolysis, and lower thrombogenicity. These factors contribute to better patient outcomes, leading to increased adoption of centrifugal blood pumps in clinical practice.
- Surge in organ transplantation: Organ transplantation, particularly heart transplantation, relies on the use of centrifugal blood pumps for circulatory support during the transplantation procedure. The increasing number of organ transplant procedures globally is driving the demand for centrifugal blood pumps.
- Research and development activities: Ongoing research and development efforts by medical device manufacturers are focused on enhancing the performance, safety, and durability of centrifugal blood pumps. These efforts result in the introduction of innovative products with improved features, further fueling market growth.
Future Opportunities Shaping the Centrifugal Blood Pumps Market’s Evolution:
The centrifugal blood pumps market is poised for significant growth, driven by advancements in pump technology and increasing clinical needs. Innovations such as magnetic levitation technology have enhanced pump reliability by reducing mechanical wear, while real-time monitoring systems improve patient safety during complex cardiac procedures. The rising prevalence of cardiovascular diseases, including heart failure and coronary artery disease, further propels the demand for efficient circulatory support devices. Additionally, the aging global population and lifestyle factors like obesity and hypertension contribute to the growing incidence of these conditions, thereby expanding the market’s potential.
Emerging markets, particularly in Asia-Pacific regions like India and Japan, present substantial opportunities for market expansion. In India, rapid healthcare infrastructure development and increased accessibility to advanced cardiac care technologies are driving demand for centrifugal blood pumps. Meanwhile, Japan’s aging demographic and high standards of healthcare delivery create a favorable environment for innovative cardiac devices. Furthermore, increased investment in cardiovascular research and development fosters the advancement of innovative technologies and therapies for cardiovascular diseases, leading to more effective and safer devices.
Market Segments Insights:
The global centrifugal blood pumps market is bifurcated into type, end-user, and geography. On the basis of type, the market is further segmented into electronic and mechanical. The electronic segment held the largest market share of around three-fourth share of the market in 2024 and is expected to maintain its dominance over the forecast period. On the other hand, the mechanical segment is accounted to expand at a massive growth rate over the forecast period.
Based on the end-user, the market is further segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospital segment dominated the global centrifugal blood pumps market in 2024 and accounted to hold the largest revenue share of around 40% of the market. The availability of skilled professionals and advanced healthcare facilities are some major factors driving the segment’s growth. Moreover, the increasing number of patient admission related to cardiac disorder is further expected to fuel the segment growth in the next upcoming years.
The centrifugal blood pumps comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market, and expert opinion obtained from interviews with industry executives and experts from prominent companies.
Centrifugal Blood Pumps Market Segmentation:
By Type:
- Electronic
- Mechanical
By End-User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage: North America Leads the Centrifugal Blood Pumps Market
Geographically, North America dominated the global centrifugal blood pumps market in 2024 and is estimated to hold a significant market share of over one-third share of the market in terms of revenue. the increasing incidence of cardiovascular disease and the increasing investment in research & development are some major factors driving the market growth in the region. Furthermore, the presence of some major players and the technological advancement in healthcare infrastructure is expected to fuel the market in North America. In contrast, the Asia Pacific is estimated to expand the market at the fastest growth rate over the forecast period.
Competition Assessment:
Some of the major players operating in the global centrifugal blood pumps market are Baxter International Inc., Medtronic PLC., Braile Biomedica Ltd., Getinge AB., and 3-M Health Care. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Baxter International Inc.
- Medtronic PLC.
- Braile Biomedica Ltd.
- Getinge AB.
- 3-M Health Care
- LivaNova, PLC.
- Qura SRL.
- Terumo Corporation
- Thoratec Corporation.
- Xenios AG.
Key Questions Answered by Centrifugal Blood Pumps Market Report
- Global centrifugal blood pumps market forecasts from 2025-2030
- Regional centrifugal blood pumps market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
- Country-level forecasts from 2025-2030 covering 15 major countries from the aforementioned regions
- Centrifugal blood pumps submarket forecasts from 2025-2030 covering the market by type, by end-user, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level markets from 2025-2030
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Centrifugal Blood Pumps Market Portraiture
2.2. Global Centrifugal Blood Pumps Market, by Type, 2020 (USD Mn)
2.3. Global Centrifugal Blood Pumps Market, by End-User, 2020 (USD Mn)
2.4. Global Centrifugal Blood Pumps Market, by Geography, 2020 (USD Mn)
3. Global Centrifugal Blood Pumps Market Analysis
3.1. Centrifugal Blood Pumps Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery
4. Global Centrifugal Blood Pumps Market By Type, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Electronic
4.3. Mechanical
5. Global Centrifugal Blood Pumps Market By End-User, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Hospitals
5.3. Ambulatory Surgical Centers
5.4. Specialty Clinics
5.5. Others
6. North America Centrifugal Blood Pumps Market Analysis and Forecast, 2018 – 2027 (USD Mn)
6.1.1. Overview
6.1.2. North America Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
6.1.3. North America Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
6.1.4. North America Centrifugal Blood Pumps Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
6.1.4.1.2. U.S. Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
6.1.4.2.2. Canada Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
7. Europe Centrifugal Blood Pumps Market Analysis and Forecast, 2018 – 2027 (USD Mn)
7.1.1. Overview
7.1.2. Europe Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
7.1.3. Europe Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
7.1.4. Europe Centrifugal Blood Pumps Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
7.1.4.1.2. Germany Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
7.1.4.2.2. U.K. Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
7.1.4.3.2. France Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
7.1.4.4.2. Italy Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
8. Asia Pacific Centrifugal Blood Pumps Market Analysis and Forecast, 2018 – 2027 (USD Mn)
8.1.1. Overview
8.1.2. Asia Pacific Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
8.1.3. Asia Pacific Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
8.1.4. Asia Pacific Centrifugal Blood Pumps Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
8.1.4.1.2. China Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
8.1.4.2.2. Japan Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
9. Latin America (LATAM) Centrifugal Blood Pumps Market Analysis and Forecast, 2018 – 2027 (USD Mn)
9.1.1. Overview
9.1.2. Latin America Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
9.1.3. Latin America Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
9.1.4. Latin America Centrifugal Blood Pumps Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
9.1.4.1.2. Brazil Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
9.1.4.2.2. Mexico Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
10. Middle East and Africa Centrifugal Blood Pumps Market Analysis and Forecast, 2018 – 2027 (USD Mn)
10.1.1. Overview
10.1.2. MEA Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
10.1.3. MEA Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
10.1.4. Middle East and Africa Centrifugal Blood Pumps Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
10.1.4.1.2. GCC Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Centrifugal Blood Pumps Market by Type (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Centrifugal Blood Pumps Market by End-User (2018-2027 USD Mn)
11. Company Profiles
11.1. Baxter International Inc.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Medtronic PLC.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Braile Biomedica Ltd.
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Getinge AB.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. 3-M Health Care
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. LivaNova, PLC.
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Qura SRL.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Terumo Corporation
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Thoratec Corporation.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Xenios AG.
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
$ 5200/- Multi User License
We understand that every business has unique requirements. This report can be customized based on:
- Deep regional & country-level market intelligence
- Application-specific and end-use industry segmentation
- Competitive landscape & strategic benchmarking
- Go-to-market and expansion strategy insights
- Custom data cuts aligned to your business goals
- Structured Primary Research Framework
- On-Demand Industry Expert Interviews Available
- Dedicated Analyst Support
- Custom Data On Request
- Post-Purchase Strategy Consultation
- Complimentary 30-min Analyst Session
- 30% of Our Clients Are Returning Enterprise Buyers